A Phase IIb, Open-Label, Randomized Controlled Dose Ranging Multi-Centre Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Exposure-Response Relationship of Different Doses of Delpazolid in Combination with Bedaquiline Delamanid Moxifloxacin in Adult Subjects with Newly Diagnosed, Uncomplicated, Smear-Positive, Drug-Sensitive Pulmonary Tuberculosis
TRIALS(2023)
关键词
Uncomplicated pulmonary tuberculosis,Treatment,Delpazolid,Randomized controlled trial,Phase IIb,Oxazolidinone
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要